Taysha Gene Therapies Reports Third Quarter 2024 Financial Results And Provides Corporate Update
High dose TSHA-102 was generally well tolerated with no SAEs or DLTs in two adolescent/adult patients and one <a target=_blank href= ...
Le Lézard13h
4 Trends That Will Shape the Workforce in 2025: Change Readiness, a Manager "Crash," the Eroding Advantages of Remote Work, and the Gen Z Paradox
Without the right support and skills, this anxiety will erode productivity ... announced that the Company will deliver two oral presentations, an oral abstract, and two posters at the International ...